JPMorgan initiated coverage of MSG Rangers stock with an overweight rating and set a $310 price target, implying 25% upside. Analyst David Karnovsky said the shares trade at an approximately 30% discount to the hockey club’s estimated value, which may be understated. Madison Square Garden Sports was separated into two publicly traded companies, MSG Rangers and MSG Knickerbockers, in October, and the stock has risen 14% month to date. A potential sale of a minority stake in the team could fund operations and shareholder returns while establishing a higher valuation benchmark. All five analysts covering the stock rate it a buy or strong buy, according to LSEG data.
Source: Read the original article


